Charles Schwab’s BioLife Solutions BLFS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $7.47M | Buy |
346,982
+6,156
| +2% | +$133K | ﹤0.01% | 2150 |
|
2025
Q1 | $7.78M | Sell |
340,826
-5,595
| -2% | -$128K | ﹤0.01% | 2067 |
|
2024
Q4 | $8.99M | Buy |
346,421
+26,462
| +8% | +$687K | ﹤0.01% | 2066 |
|
2024
Q3 | $8.01M | Buy |
319,959
+9,750
| +3% | +$244K | ﹤0.01% | 2140 |
|
2024
Q2 | $6.65M | Buy |
310,209
+5,939
| +2% | +$127K | ﹤0.01% | 2222 |
|
2024
Q1 | $5.64M | Buy |
304,270
+19,146
| +7% | +$355K | ﹤0.01% | 2238 |
|
2023
Q4 | $4.63M | Buy |
285,124
+3,126
| +1% | +$50.8K | ﹤0.01% | 2342 |
|
2023
Q3 | $3.89M | Buy |
281,998
+16,754
| +6% | +$231K | ﹤0.01% | 2362 |
|
2023
Q2 | $5.86M | Buy |
265,244
+7,389
| +3% | +$163K | ﹤0.01% | 2174 |
|
2023
Q1 | $5.61M | Buy |
257,855
+3,889
| +2% | +$84.6K | ﹤0.01% | 2149 |
|
2022
Q4 | $4.62M | Buy |
253,966
+5,191
| +2% | +$94.5K | ﹤0.01% | 2251 |
|
2022
Q3 | $5.66M | Buy |
248,775
+23,078
| +10% | +$525K | ﹤0.01% | 2150 |
|
2022
Q2 | $3.12M | Buy |
225,697
+53,425
| +31% | +$738K | ﹤0.01% | 2394 |
|
2022
Q1 | $3.92M | Buy |
172,272
+6,628
| +4% | +$151K | ﹤0.01% | 2386 |
|
2021
Q4 | $6.17M | Sell |
165,644
-27,429
| -14% | -$1.02M | ﹤0.01% | 2244 |
|
2021
Q3 | $8.17M | Sell |
193,073
-10,105
| -5% | -$428K | ﹤0.01% | 2128 |
|
2021
Q2 | $9.04M | Buy |
203,178
+54,000
| +36% | +$2.4M | ﹤0.01% | 2056 |
|
2021
Q1 | $5.37M | Buy |
149,178
+5,441
| +4% | +$196K | ﹤0.01% | 2265 |
|
2020
Q4 | $5.73M | Buy |
143,737
+5,260
| +4% | +$210K | ﹤0.01% | 2148 |
|
2020
Q3 | $4.01M | Buy |
138,477
+116,108
| +519% | +$3.36M | ﹤0.01% | 2184 |
|
2020
Q2 | $366K | Buy |
22,369
+3,971
| +22% | +$65K | ﹤0.01% | 2957 |
|
2020
Q1 | $175K | Hold |
18,398
| – | – | ﹤0.01% | 3033 |
|
2019
Q4 | $298K | Buy |
18,398
+1,402
| +8% | +$22.7K | ﹤0.01% | 2972 |
|
2019
Q3 | $283K | Buy |
16,996
+307
| +2% | +$5.11K | ﹤0.01% | 2980 |
|
2019
Q2 | $283K | Buy |
+16,689
| New | +$283K | ﹤0.01% | 3034 |
|